These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 11093731
1. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731 [Abstract] [Full Text] [Related]
2. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Fukui H. Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832 [Abstract] [Full Text] [Related]
12. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats]. Zhang F, Ma J, Lu Y, Ni GX, Ni CY, Zhang XJ, Wang AY, Zheng SZ. Zhen Ci Yan Jiu; 2012 Feb 17; 37(1):8-14. PubMed ID: 22574562 [Abstract] [Full Text] [Related]
13. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. Deng YR, Ma HD, Tsuneyama K, Yang W, Wang YH, Lu FT, Liu CH, Liu P, He XS, Diehl AM, Gershwin ME, Lian ZX. J Autoimmun; 2013 Oct 17; 46():25-34. PubMed ID: 23948302 [Abstract] [Full Text] [Related]
14. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells. Suárez-Cuenca JA, Chagoya de Sánchez V, Aranda-Fraustro A, Sánchez-Sevilla L, Martínez-Pérez L, Hernández-Muñoz R. Exp Biol Med (Maywood); 2008 Jul 17; 233(7):827-39. PubMed ID: 18445764 [Abstract] [Full Text] [Related]
15. Expression of tissue inhibitor of matrix metalloproteinase-1 in aging of transgenic mouse liver. Zhang YM, Chen XM, Wu D, Zhang XG, Lü Y, Shi SZ, Yin Z. Chin Med J (Engl); 2006 Mar 20; 119(6):504-9. PubMed ID: 16584649 [Abstract] [Full Text] [Related]
17. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis. Horani A, Muhanna N, Pappo O, Melhem A, Alvarez CE, Doron S, Wehbi W, Dimitrios K, Friedman SL, Safadi R. Am J Physiol Gastrointest Liver Physiol; 2007 Feb 20; 292(2):G628-38. PubMed ID: 17038628 [Abstract] [Full Text] [Related]
18. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis. Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y, Peng Z, Wu P, Tong X, Chen J, Li H, Cong R, Tang S, Wang B, Jia J, You H. Am J Pathol; 2013 May 20; 182(5):1607-16. PubMed ID: 23474083 [Abstract] [Full Text] [Related]
19. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Jin Z, Sun R, Wei H, Gao X, Chen Y, Tian Z. Hepatology; 2011 Jan 20; 53(1):219-29. PubMed ID: 21140473 [Abstract] [Full Text] [Related]
20. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. Choi SS, Sicklick JK, Ma Q, Yang L, Huang J, Qi Y, Chen W, Li YX, Goldschmidt-Clermont PJ, Diehl AM. Hepatology; 2006 Nov 20; 44(5):1267-77. PubMed ID: 17058265 [Abstract] [Full Text] [Related] Page: [Next] [New Search]